# NHS Framework Agreement for Aflibercept injection and Ranibizumab injection

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £1,220,000,000
- Published: 3 July 2018
- Planned start: 1 October 2018
- Planned end: 30 September 2020
- Stage: open_tender
- Procurement category: goods
- Notice ID: d18aaa94-0e16-4f83-a972-a4171450a216-225936
- OCID: ocds-b5fd17-2185a72e-57ad-4f00-ad8b-25bf58fff2b3

## Description

NHS Framework Agreement for Proprietary Pharmaceuticals - Afliercept and Ranibizumab ophthalmology products Offer reference number: CM/PHR/17/5561 Period of framework agreement: 1 August 2018 - 31 July 2020 \(at the Authority's discretion\) for a period or periods up to a total of 24 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/d18aaa94-0e16-4f83-a972-a4171450a216-225936)